Completed PHASE4 INTERVENTIONAL 3-arm NCT01998438

Prospective Trial of Tranexamic Acid in Cardiac Surgery

A Randomized Double-blinded Trial to Explore the Optimum Dose of Tranexamic Acid in Cardiopulmonary Bypass Cardiac Surgery

Sponsor: Hongwen Ji

Conditions C.Surgical Procedure; Cardiac

Interventions Tranexamic Acid

Updated 7 times since 2017 Last updated: Jan 29, 2016 Started: Sep 30, 2012 Primary completion: Sep 30, 2014 Completion: Sep 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates C.Surgical Procedure; Cardiac and is currently completed. Hongwen Ji leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hongwen Ji

Data source: Chinese Academy of Medical Sciences, Fuwai Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China